Key Points 1. The aim of this Voucher Scheme is to enable projects addressing significant scientific challenges using synthetic biology capabilities at NCRIS SynBio and NCRIS Partner facilities. 2. Applications for a Primary Voucher will include a Lead Provider from...
A Sydney tech entrepreneur has used artificial intelligence and genomics to develop a personalised mRNA cancer vaccine for his rescue dog, Rosie, offering hope for both veterinary and human cancer treatments. When Rosie was diagnosed with advanced mast cell cancer,...
Three startups supported by Bioplatforms Australia have been announced as recipients of the NSW Government’s Emerging Technology Commercialisation Fund, recognising the strength of Australia’s deep-tech pipeline and the role of national research infrastructure in...
Australia is home to one of the world’s most diverse arrays of venomous species, yet the vast majority remain poorly characterised at the molecular level. The Australian Venom Innovation and Discovery (AVID) Initiative is addressing this gap through a national...
A new joint white paper from the Australian NCRIS Health Group and the European Life Sciences Research Infrastructure Strategy Board sets out a shared vision for building a structured, well-resourced Australia–Europe research infrastructure ecosystem in health and...
Bioplatforms Australia, enabled by NCRIS investment in research infrastructure, is committed to supporting the Australian life sciences community through a diverse access program, provision of targeted infrastructure requirements, and making integrated capability...
